<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>OPTIMIZING MULTIDISCIPLINARY STRATEGIES FOR ALLEVIATING PELVIC DISCOMFORT IN WOMEN WITH PERSISTENT ENDOMETRIAL INFLAMMATION</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Tursoatova</mods:namePart><mods:namePart type="family">Sh.M</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Tursoatova</mods:namePart><mods:namePart type="family">Sh.M</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Tilyavova</mods:namePart><mods:namePart type="family">S.A</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Persistent endometrial inflammation, or chronic endometritis (CE), affects 12–25% of women seeking reproductive care, often manifesting as debilitating pelvic discomfort that disrupts daily life. In Uzbekistan, where CE is diagnosed in 10–18% of gynecological patients, fragmented care exacerbates suffering. This randomized controlled trial (RCT) explored innovative multidisciplinary strategies—targeted antibiotics, acupuncture, and mindfulness-based stress reduction (MBSR)—to relieve pelvic discomfort in 160 women aged 20–40 across Tashkent, Fergana, and Bukhara clinics from March 2023 to December 2024. Participants were randomized into four groups: antibiotics, acupuncture, integrated (antibiotics-acupuncture-MBSR), and usual care (control). Primary outcomes were discomfort severity (Pelvic Pain Impact Questionnaire, PPIQ) and inflammatory resolution (biopsy-confirmed). Secondary outcomes included emotional well-being (PHQ-9), fertility potential (ovulatory cycles), and intervention uptake at 8 weeks and 6 months. The integrated group reduced PPIQ scores by 50% (8.5 ± 1.5 to 4.3 ± 1.0, p&amp;lt;0.001) and achieved 80% inflammatory resolution versus 50% in controls (p&amp;lt;0.01). Acupuncture alone eased discomfort by 35%, and antibiotics resolved inflammation in 65%. Emotional well-being improved markedly in the integrated group (PHQ-9 6 ± 2 vs. 12 ± 3 in controls, p&amp;lt;0.001). These results champion a holistic approach, offering Uzbekistan a practical framework to enhance women’s health and informing global CE care.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-04-15</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Center for Tech and Media Research</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>